New York Times reports on a project set to kick off in the next few months in which three medical research centers -- the University of Michigan Comprehensive Cancer Center, Dana-Farber Cancer Institute, and Baylor College of Medicine -- will begin testing patients for the presence of cancerous stem cells to see if there's hope for therapeutically targeting them in the future.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The New York Times reports that as China invests in science, it also is dealing with research fraud.

In PLOS this week: transcriptome study of a cold-tolerant plant, deep sequencing of clinical influenza A samples, and more.

The Atlantic writes that retrotransposons like BovB have proliferated in a number of genomes.

Researchers have sequenced the genome of a man who lived in China some 40,000 years ago, according to UPI.